Microglia depletion/repopulation does not affect light-induced retinal degeneration in mice
Nils Laudenberg1, Urbanus Muthai Kinuthia1,2, Thomas Langmann1,2
1Laboratory for Experimental Immunology of the Eye, Department of Ophthalmology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Frontiers in Immunology
|January 30, 2024
Summary
Microglia depletion in retinal degeneration models reduces inflammation but does not prevent photoreceptor loss. Repopulation also failed to protect against light-induced damage, suggesting limited therapeutic benefit.
Area of Science:
- Ophthalmology
- Neuroscience
- Immunology
Background:
- Reactive microglia are implicated in age-related retinal diseases like AMD.
- While contributing to neuroinflammation, microglia also have essential immune-regulatory roles in the retina.
Purpose of the Study:
- To investigate the impact of microglia depletion and repopulation on light-induced retinal degeneration.
- To assess the role of microglia in photoreceptor survival and inflammation in a dry AMD model.
Main Methods:
- Utilized PLX3397, a CSF1R antagonist, for microglia depletion in a mouse model.
- Evaluated retinal degeneration using optical coherence tomography (OCT) and histology.
- Assessed pro-inflammatory factor expression and photoreceptor death.
Main Results:
- Microglia depletion reduced pro-inflammatory factors but did not alter the extent of retinal degeneration.
- Observed significant cell debris accumulation in depleted retinas, indicating impaired phagocytosis.
- Microglia repopulation did not prevent photoreceptor death or reduce microglia activation under light damage.
Conclusions:
- Microglia ablation decreases inflammation but does not prevent photoreceptor loss in this model.
- The phagocytic capacity of microglia is crucial for clearing debris in retinal degeneration.
- Targeting microglia solely for depletion may not be a sufficient therapeutic strategy for AMD.
